“Based on the data and the circumstances alone, it is not possible to conclude that the vaccine was the cause of the deaths,” Prof. Nagao said, adding, “However, it is impossible to say that the vaccine was not the cause. We can only say that it is doubtful, but we believe that vaccination was sufficiently related to the immune abnormalities.”
“In the last week, hospitalization rates have increased by 17% among all age groups with confirmed COVID cases.”
https://www.foxnews.com/lifestyle/covid-hospitalizations-deaths-rise-coming-weeks-according-cdc
“The experience of the past year has taught us that chasing these Omicron variants with a bivalent vaccine is a losing game,” says Offit, director of the vaccine education center at the Children’s Hospital of Philadelphia and a member of the U.S. Food and Drug Administration’s vaccine advisory committee.”
https://time.com/6246525/bivalent-booster-not-very-effective-paul-offit/
“That data suggested the possibility that the updated booster might not be any more effective at preventing Covid-19 infections than the original shots.”
https://www.cnn.com/2023/01/11/health/moderna-bivalent-transparency/index.html
“Masks interfered with O2-uptake and CO2-release and compromised respiratory compensation. Though evaluated wearing durations do not represent daily/prolonged use, outcomes independently validate mask-induced exhaustion-syndrome (MIES). MIES can have long-term clinical consequences, especially for vulnerable groups.”
https://www.researchsquare.com/article/rs-2394501/v1
“As of July 2022, only 24.4 percent of the population in Africa had received at least one dose of a Covid shot in comparison with the global average of 69 percent. Only three African countries, Liberia, Mauritius and Seychelles have 70 percent of their population vaccinated.”
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org
.svg){kind=small}
